# OnCo record radiomer-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/radiomer-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "radiomer-therapeutics" ;
  schema:name "Radiomer Therapeutics"@en ;
  schema:description "Radiomer Therapeutics is a Houston start-up building radioactive cancer drugs that use a new kind of homing molecule, part DNA and part protein, to find tumour cells. It planned small imaging studies in patients first, before moving to treatment."@en ;
  schema:url <https://onco.cc/companies/radiomer-therapeutics/>, <https://www.radiomer.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.radiomer.com/>, <https://www.prweb.com/releases/fannin-launches-radiomer-therapeutics-with-novel-targeting-vectorligand-platform-for-radiopharmaceuticals-302156353.html>, <https://houston.innovationmap.com/houston-fannin-partners-radiomer-therapeutics-2668405362.html> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> .